Lipocine Inc. (LPCN) stock
LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.60−0.06 (-3.61%)
Close on Nov 17, 2026Market cap $13.19MP/E –Yield –
Lipocine market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Lipocine's market cap was $13.11M on Nov 11, 2026, against $18.65M a year earlier. Over the last 5 years it ranged from $11.87M to $120.97M, with a median of $24.28M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.11M | -69.9% |
| 2025 | Dec 31, 2025 | $43.52M | +66.8% |
| 2024 | Dec 31, 2024 | $26.10M | +76.0% |
| 2023 | Dec 29, 2023 | $14.83M | -57.9% |
| 2022 | Dec 30, 2022 | $35.21M | -59.8% |
| 2021 | Dec 31, 2021 | $87.51M | -2.0% |
| 2020 | Dec 31, 2020 | $89.34M | +827.3% |
| 2019 | Dec 31, 2019 | $9.63M | -65.3% |
| 2018 | Dec 31, 2018 | $27.74M | -61.9% |
| 2017 | Dec 29, 2017 | $72.86M | +8.5% |
| 2016 | Dec 30, 2016 | $67.18M | -71.5% |
| 2015 | Dec 31, 2015 | $235.89M | +250.9% |
| 2014 | Dec 31, 2014 | $67.22M | -25.6% |
| 2013 | Dec 31, 2013 | $90.36M | – |
See a number that looks wrong?